Recombinant factor VIIa for treatment of gastrointestinal hemorrhage following rattlesnake envenomation

Wilderness and Environmental Medicine

Volumn 20, Issue 2, 2009, Pages 156-160

  Ruha, Anne Michelle ^a,b,c,d   Curry, Steven C ^a,b,c  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b MARICOPA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Hemorrhage; Rattlesnake; Recombinant factor VIIa

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SNAKE VENOM ANTISERUM;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY WARD; ENVENOMATION; ESOPHAGOGASTRODUODENOSCOPY; GASTROINTESTINAL HEMORRHAGE; GRAM NEGATIVE SEPSIS; HUMAN; LABORATORY TEST; MALE; MALLORY WEISS SYNDROME; PHYSICAL EXAMINATION; SNAKE; SNAKEBITE; THROMBOCYTOPENIA;

EID: 67649519990     PISSN: 10806032     EISSN: None     Source Type: Journal    
DOI: 10.1580/08-WEME-CR-229R1.1     Document Type: Article

References (12)

1. Gold BS, Dart RC, Barish RA. Current concepts: bites of venomous snakes. N Engl J Med. 2002;347:347-356. (Pubitemid 34815358)
2. Holstege CP, Miller MB, Wermuth M, et al. Crotalid snake envenomation. Crit Care Clin. 1997;13:889-921. (Pubitemid 27432897)
3. Kitchens CS. Hemostatic aspects of envenomation by North American snakes. Hematol Oncol Clin North Am. 1992;6:1189-1195.
4. Tanen DA, Ruha AM, Graeme KA, Curry SC. Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in central Arizona. Acad Emerg Med. 2001;8:177-182. (Pubitemid 32125340)
5. Hutton RA, Warrell DA. Action of snake venom components on the haemostatic system. Blood Rev. 1993;7:176-189. (Pubitemid 23276024)
6. CroFab package insert. Available at: http://www.fda.gov/cber/label/ cropro100200LB.pdf. Accessed October 20, 2008.
7. Levi M, Peters M, Buller HR. Efficacy and safety of recombinant factor VIIa for treatment for severe bleeding: a systematic review. Crit Care Med. 2005;33:883-890. (Pubitemid 40504401)
8. Hedner U. Mechanism of action, development, and clinical experience of recombinant FVIIa. J Biotech. 2006;124:747-757. (Pubitemid 44066599)
9. Patanwala AE. Factor VIIa (recombinant) for acute traumatic hemorrhage. Am J Health-Syst Pharm. 2008;65:1616-1623.
10. Enomoto TM, Thorborg P. Emerging off-label uses for recombinant activated factor VII: grading the evidence. Crit Care Med. 2005;21:611-632. (Pubitemid 40898161)
11. Curry SC, Kunkel DB. Death from a rattlesnake bite. Am J Emerg Med. 1985;3:227-235. (Pubitemid 15086407)
12. Levi M. Current understanding of disseminated intravascular coagulation. Br J Hematol. 2004;124:567-576. (Pubitemid 38297089)